Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Toronto
$105,000.00
Investigating altered sensory function in a peripheral nervous system organoid model of autism spectrum disorder
FY 2023-24
Summary
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by deficits in social communication and patterns of restricted, repetitive behaviours. Sensory changes have been reported in up to 95% of individuals with ASD, however the biological mechanisms driving these changes are not well understood. Despite strong prevalence and repeated association with ASD severity, sensory deficits were historically thought to be peripheral phenomena rather than core features of ASD. New evidence demonstrating that disrupting ASD risk genes in the developing mouse peripheral nervous system (PNS) can drive brain region-specific and behavioural changes challenges this central "top-down" belief. Here, we draw from classical work to revisit the contribution of critical period somatosensory dysfunction in early human neurodevelopment.
The regulation of protein synthesis is shared among many ASD risk genes. Intriguingly, genetic changes to several high-risk protein regulatory genes, including FMR1 and CYFIP1, also manifest in sensory changes, particularly somatosensory (touch and pain) processing. Mouse models have primarily been used to infer sensory dysfunction from a cell activity perspective, but a broader investigation of ASD somatosensory nervous system development is lacking. The use of a human-specific model can not only provide insight into the cellular and molecular mechanisms underlying somatosensory deficits in ASD but may also be used to establish neurotypical events in vitro.
I have recently developed a protocol to generate 3D human sensory organoids that recapitulate fundamental somatosensory cell development. I will generate stem cell-derived DRGOs lacking FMR1 or CYFIP1 gene expression as a model to examine the biological basis of human somatosensory dysfunction in the PNS. I hypothesize that altered human PNS somatosensory function directly contributes to pathophysiological mechanisms underlying ASD via changes in protein synthesis regulation.
Department
Program
Doctoral Research Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
496539
Name
Irwin Courtney L
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Investigating altered sensory function in a peripheral nervous system organoid model of autism spectrum disorder
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Autism Spectrum Disorder (Asd); Dorsal Root Ganglia (Drg); Human Pluripotent Stem Cells (Hpscs); Neurodevelopmental Disorders (Ndds); Organoids; Satellite Glia; Schwann Cells; Sensory Nervous System; Sensory Neurons; Somatosensory Development
Abstract
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by deficits in social communication and patterns of restricted, repetitive behaviours. Sensory changes have been reported in up to 95% of individuals with ASD, however the biological mechanisms driving these changes are not well understood. Despite strong prevalence and repeated association with ASD severity, sensory deficits were historically thought to be peripheral phenomena rather than core features of ASD. New evidence demonstrating that disrupting ASD risk genes in the developing mouse peripheral nervous system (PNS) can drive brain region-specific and behavioural changes challenges this central "top-down" belief. Here, we draw from classical work to revisit the contribution of critical period somatosensory dysfunction in early human neurodevelopment.
The regulation of protein synthesis is shared among many ASD risk genes. Intriguingly, genetic changes to several high-risk protein regulatory genes, including FMR1 and CYFIP1, also manifest in sensory changes, particularly somatosensory (touch and pain) processing. Mouse models have primarily been used to infer sensory dysfunction from a cell activity perspective, but a broader investigation of ASD somatosensory nervous system development is lacking. The use of a human-specific model can not only provide insight into the cellular and molecular mechanisms underlying somatosensory deficits in ASD but may also be used to establish neurotypical events in vitro.
I have recently developed a protocol to generate 3D human sensory organoids that recapitulate fundamental somatosensory cell development. I will generate stem cell-derived DRGOs lacking FMR1 or CYFIP1 gene expression as a model to examine the biological basis of human somatosensory dysfunction in the PNS. I hypothesize that altered human PNS somatosensory function directly contributes to pathophysiological mechanisms underlying ASD via changes in protein synthesis regulation.
Competitiondate
202311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Irwin, Courtney L
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~